535 related articles for article (PubMed ID: 25753968)
1. Anticoagulation after catheter ablation of atrial fibrillation guided by implantable cardiac monitors.
Zuern CS; Kilias A; Berlitz P; Seizer P; Gramlich M; Müller K; Duckheim M; Gawaz M; Schreieck J
Pacing Clin Electrophysiol; 2015 Jun; 38(6):688-93. PubMed ID: 25753968
[TBL] [Abstract][Full Text] [Related]
2. Risk of stroke or transient ischemic attack after atrial fibrillation ablation with oral anticoagulant use guided by ECG monitoring and pulse assessment.
Riley MP; Zado E; Hutchinson MD; Lin D; Bala R; Garcia FC; Callans DJ; Cooper JM; Verdino RJ; Dixit S; Marchlinski FE
J Cardiovasc Electrophysiol; 2014 Jun; 25(6):591-6. PubMed ID: 24533561
[TBL] [Abstract][Full Text] [Related]
3. Very low risk of thromboembolic events in patients undergoing successful catheter ablation of atrial fibrillation with a CHADS2 score ≤3: a long-term outcome study.
Saad EB; d'Avila A; Costa IP; Aryana A; Slater C; Costa RE; Inácio LA; Maldonado P; Neto DM; Camiletti A; Camanho LE; Polanczyk CA
Circ Arrhythm Electrophysiol; 2011 Oct; 4(5):615-21. PubMed ID: 21841192
[TBL] [Abstract][Full Text] [Related]
4. [Anticoagulation in high thromboembolic risk after catheter ablation for atrial fibrillation: results from the German Ablation Registry].
Moser J; Kuck KH; Andresen D; Spitzer SG; Hoffmann E; Schumacher B; Eckardt L; Brachmann J; Lewalter T; Hochadel M; Senges J; Willems S; Hoffmann BA
Dtsch Med Wochenschr; 2014 Sep; 139(39):1923-8. PubMed ID: 25225860
[TBL] [Abstract][Full Text] [Related]
5. Continuous rhythm monitoring-guided anticoagulation after atrial fibrillation ablation.
Pothineni NVK; Amankwah N; Santangeli P; Schaller RD; Supple GE; Deo R; Nazarian S; Garcia FC; Dixit S; Callans DJ; Marchlinski FE; Frankel DS
J Cardiovasc Electrophysiol; 2021 Feb; 32(2):345-353. PubMed ID: 33382500
[TBL] [Abstract][Full Text] [Related]
6. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial.
Di Biase L; Burkhardt JD; Santangeli P; Mohanty P; Sanchez JE; Horton R; Gallinghouse GJ; Themistoclakis S; Rossillo A; Lakkireddy D; Reddy M; Hao S; Hongo R; Beheiry S; Zagrodzky J; Rong B; Mohanty S; Elayi CS; Forleo G; Pelargonio G; Narducci ML; Dello Russo A; Casella M; Fassini G; Tondo C; Schweikert RA; Natale A
Circulation; 2014 Jun; 129(25):2638-44. PubMed ID: 24744272
[TBL] [Abstract][Full Text] [Related]
7. A more specific anticoagulation regimen is required for patients after the cox-maze procedure.
Ad N; Henry L; Shuman DJ; Holmes SD
Ann Thorac Surg; 2014 Oct; 98(4):1331-8. PubMed ID: 25152383
[TBL] [Abstract][Full Text] [Related]
8. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A
Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706
[TBL] [Abstract][Full Text] [Related]
9. Are implantable cardiac monitors the 'gold standard' for atrial fibrillation detection? A prospective randomized trial comparing atrial fibrillation monitoring using implantable cardiac monitors and DDDRP permanent pacemakers in post atrial fibrillation ablation patients.
Podd SJ; Sugihara C; Furniss SS; Sulke N
Europace; 2016 Jul; 18(7):1000-5. PubMed ID: 26585596
[TBL] [Abstract][Full Text] [Related]
10. Assessing arrhythmia burden after catheter ablation of atrial fibrillation using an implantable loop recorder: the ABACUS study.
Kapa S; Epstein AE; Callans DJ; Garcia FC; Lin D; Bala R; Riley MP; Hutchinson MD; Gerstenfeld EP; Tzou W; Marchlinski FE; Frankel DS; Cooper JM; Supple G; Deo R; Verdino RJ; Patel VV; Dixit S
J Cardiovasc Electrophysiol; 2013 Aug; 24(8):875-81. PubMed ID: 23577826
[TBL] [Abstract][Full Text] [Related]
11. Oral anticoagulation is frequently discontinued after ablation of paroxysmal atrial fibrillation despite previous stroke: data from the German Ablation Registry.
Nührich JM; Kuck KH; Andresen D; Steven D; Spitzer SG; Hoffmann E; Schumacher B; Eckardt L; Brachmann J; Lewalter T; Hochadel M; Senges J; Willems S; Hoffmann BA
Clin Res Cardiol; 2015 Jun; 104(6):463-70. PubMed ID: 25537233
[TBL] [Abstract][Full Text] [Related]
12. Role of cardiovascular implantable electronic devices in delivering individualized disease-guided management of patients with non-valvular atrial fibrillation and high bleeding risk.
Mascarenhas DAN; Sharma M; Ziegler PD; Kantharia BK
Acta Cardiol; 2019 Apr; 74(2):131-139. PubMed ID: 29863432
[TBL] [Abstract][Full Text] [Related]
13. Influence of periprocedural anticoagulation strategies on complication rate and hospital stay in patients undergoing catheter ablation for persistent atrial fibrillation.
Gunawardene M; Willems S; Schäffer B; Moser J; Akbulak RÖ; Jularic M; Eickholt C; Nührich J; Meyer C; Kuklik P; Sehner S; Czerner V; Hoffmann BA
Clin Res Cardiol; 2017 Jan; 106(1):38-48. PubMed ID: 27435077
[TBL] [Abstract][Full Text] [Related]
14. Patterns of Anticoagulation Use and Cardioembolic Risk After Catheter Ablation for Atrial Fibrillation.
Noseworthy PA; Yao X; Deshmukh AJ; Van Houten H; Sangaralingham LR; Siontis KC; Piccini JP; Asirvatham SJ; Friedman PA; Packer DL; Gersh BJ; Shah ND
J Am Heart Assoc; 2015 Nov; 4(11):. PubMed ID: 26541393
[TBL] [Abstract][Full Text] [Related]
15. Oral anticoagulation after atrial fibrillation catheter ablation: benefits and risks.
Kanaoka K; Nishida T; Iwanaga Y; Nakai M; Tonegawa-Kuji R; Nishioka Y; Myojin T; Okada K; Noda T; Kusano K; Miyamoto Y; Saito Y; Imamura T
Eur Heart J; 2024 Feb; 45(7):522-534. PubMed ID: 38117227
[TBL] [Abstract][Full Text] [Related]
16. Anticoagulant cessation following atrial fibrillation ablation: limits of the ECG-guided approach.
Anselmino M; Rovera C; Marchetto G; Ferraris F; Castagno D; Gaita F
Expert Rev Cardiovasc Ther; 2017 Jun; 15(6):473-479. PubMed ID: 28514878
[TBL] [Abstract][Full Text] [Related]
17. Targeted Anticoagulation for Atrial Fibrillation Guided by Continuous Rhythm Assessment With an Insertable Cardiac Monitor: The Rhythm Evaluation for Anticoagulation With Continuous Monitoring (REACT.COM) Pilot Study.
Passman R; Leong-Sit P; Andrei AC; Huskin A; Tomson TT; Bernstein R; Ellis E; Waks JW; Zimetbaum P
J Cardiovasc Electrophysiol; 2016 Mar; 27(3):264-70. PubMed ID: 26511221
[TBL] [Abstract][Full Text] [Related]
18. Novel oral anticoagulants in a real-world cohort of patients undergoing catheter ablation of atrial fibrillation.
Eitel C; Koch J; Sommer P; John S; Kircher S; Bollmann A; Arya A; Piorkowski C; Hindricks G
Europace; 2013 Nov; 15(11):1587-93. PubMed ID: 23703362
[TBL] [Abstract][Full Text] [Related]
19. Oral Anticoagulation After Successful Atrial Fibrillation Ablation Operations: Is It Necessary?
Schlingloff F; Oberhoffer M; Quasdorff I; Wohlmuth P; Schmoeckel M; Geidel S
Ann Thorac Surg; 2016 Apr; 101(4):1471-6. PubMed ID: 26627178
[TBL] [Abstract][Full Text] [Related]
20. Long-term oral anticoagulation for patients after successful catheter ablation of atrial fibrillation: is it necessary?
Ha AC; Hindricks G; Birnie DH; Verma A
Curr Opin Cardiol; 2015 Jan; 30(1):1-7. PubMed ID: 25389647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
